Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

857 ARTÍCULOS , VIENDO DEL 766 AL 780

Multimodal Imaging Markers of Cognitive Resilience and Molecular Mechanisms of Brain Resilience in Alzheimer's Disease

Yang Z, Sheng J, Zhang Q, Zhao X, Song Y, Dong G, Zhang R, Zhao H, Wang J, Pan R, Zhu H.

J Integr Neurosci. 2025 May 16;24(5):26584. doi: 10.31083/JIN26584.

Signaling Molecules and Diagnosis of Cognitive Disorders: Current State and Prospects

Kvetnoy I, Kheyfets O, Safaniev L, Kheifets V, Mironova E, Kvetnaia T, Mazzoccoli G, Prashchayeu K, Gavrilova A.

Int J Mol Sci. 2025 Dec 29;27(1):372. doi: 10.3390/ijms27010372.

Blood-Based Tau as a Biomarker for Early Detection and Monitoring of Alzheimer's Disease: A Systematic Review and Meta-Analysis

Kim KY, Shin KY, Chang KA.

Int J Mol Sci. 2025 Oct 23;26(21):10330. doi: 10.3390/ijms262110330.

Comparing high and low amyloid producers in Alzheimer's disease: An in-depth analysis

Leroy M, Aziz AL, Schraen S, Deramecourt V, Skrobala E, Lecerf S, Pasquier F, Huin V, Bertoux M, Lebouvier T.

Rev Neurol (Paris). 2025 Apr;181(4):332-341. doi: 10.1016/j.neurol.2025.02.004. Epub 2025 Mar 7.

Associations of depressive symptoms and cortisol with cognitive performance among memory clinic patients

Adedeji DO, Holleman J, Johansson L, Kåreholt I, Aspö M, Hagman G, Akenine U, Overton M, Solomon A, Kivipelto M, Sindi S, Sacuiu SF.

Int Psychogeriatr. 2025 Mar;37(2):100009. doi: 10.1016/j.inpsyc.2024.100009. Epub 2024 Dec 4.

Neurodegeneration and glial activation related blood biomarkers in Alzheimer's disease: A systematic review and an updated meta- analysis

Ebrahimi R, Salehi Amniyeh Khozani AA, Masouri MM, Seifi M, Hashempoor A, Mohammad Soltani S, Noori S.

Exp Gerontol. 2025 Dec;212:112960. doi: 10.1016/j.exger.2025.112960. Epub 2025 Nov 14.

Effect of probiotics on cognitive function and cardiovascular risk factors in mild cognitive impairment and Alzheimer's disease: an umbrella meta-analysis

Xiao B, Fu L, Yang Z, Yu G.

J Health Popul Nutr. 2025 Apr 8;44(1):109. doi: 10.1186/s41043-025-00816-3.

Clinical definition, biological characterization, and detection guidelines of subjective cognitive decline due to Alzheimer's disease and related dementia: A position paper from ISTAART SCD PIA

Moretti DV, Kuhn E, Dubbelmann MA, Sikkes SAM, Castilhos RM, Chapman S, Gifford KA, Butterbrod E, Nosheny RL; Subjective Cognitive Decline Professional Interest Area, Alzheimer's Association ISTAART.

Alzheimers Dement. 2025 Dec;21(12):e70847. doi: 10.1002/alz.70847.

A phase 2A/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD

Erichsen JM, Register TC, Sutphen C, Ma D, Gaussoin SA, Rudolph M, Rundle M, Bateman JT, Lockhart SN, Sai KKS, Whitlow C, Craft S.

Alzheimers Dement. 2025 Oct;21(10):e70704. doi: 10.1002/alz.70704.

Evaluating the Predictive Value of Oxylipins for Cognitive Measures and White Matter Hyperintensities in Alzheimer's Disease Continuum Compared to Conventional Beta‑amyloid and Tau Protein Biomarkers

Shaabanpoor Haghighi A, Mayeli M, Ramezannezhad E, Pouroushaninia N, Barzegar Parizi R, Nourollahi-Foumeshi M, Idelkhani N, Dadjou Z, Saeedipour N, Safaee N, Partoandaz H, Shafie M, Sadeghi M, Falahati M; Alzheimer’s Disease Neuroimaging Initiative.

Mol Neurobiol. 2025 Nov;62(11):14156-14166. doi: 10.1007/s12035-025-05185-w. Epub 2025 Jul 16.

Inflammatory Markers and their Relationship with Cognitive Function in Alzheimer's Disease and Mild Cognitive Impairment. Systematic Review and Meta-Analysis

Serna MF, Mosquera M, García-Perdomo HA.

Neuromolecular Med. 2025 Jul 25;27(1):53. doi: 10.1007/s12017-025-08866-w.

Untangling the Genetic Threads of Alzheimer's: Insights into Risk Factors and Biomarkers

Naiyeri A, Moqadami A, Khalaj-Kondori M.

Curr Gene Ther. 2025;25(5):646-662. doi: 10.2174/0115665232338503241227111640.

The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery

Videla L, Benejam B, Barroeta I, Fernandez S, Altuna M, Arranz J, Rodríguez-Baz Í, Arriola-Infante JE, Maure-Blesa L, Del Hoyo Soriano L, Illán-Gala I, Estellés T, Sanjuan A, Vaqué-Alcázar L, Aranha MR, Morcillo-Nieto AO, Zsadanyi SE, Franquesa-Mullerat M, Valldeneu S, Sánchez-Saudinós MB, Padilla C, Carreras M, Lorente O, Valle-Tamayo N, Sánchez-Aced É, Dols-Icardo O, Sirisi S, Muñoz L, Torres S, Bounasr El Bennadi SE, Sánchez O, Garzón D, Ribas L, Elbachiri S, Mota C, Tondo M, Camacho V, Giménez S, Delaby C, Belbin O, Iulita MF, Montal V, Pegueroles J, Vilaplana E, Clarimón J, González-Ortiz S, Molina-Porcel L, Aldecoa I, Alcolea D, Bejanin A, Videla S, Blesa R, Lleó A, Carmona-Iragui M, Fortea J.

Alzheimers Dement. 2025 Jun;21(6):e70259. doi: 10.1002/alz.70259.

The moderating effect of cognitive reserve on the association between neuroimaging biomarkers and cognition: A systematic review

Guo L, Zhou Y, Lu H, Fung HH.

Neurobiol Aging. 2025 Dec;156:10-29. doi: 10.1016/j.neurobiolaging.2025.07.016. Epub 2025 Jul 30.

"Fill States": PET-derived Markers of the Spatial Extent of Alzheimer Disease Pathology

Doering E, Hoenig MC, Giehl K, Dzialas V, Andrassy G, Bader A, Bauer A, Elmenhorst D, Ermert J, Frensch S, Jäger E, Jessen F, Krapf P, Kroll T, Lerche C, Lothmann J, Matusch A, Neumaier B, Onur OA, Ramirez A, Richter N, Sand F, Tellmann L, Theis H, Zeyen P, van Eimeren T, Drzezga A, Bischof GN; Alzheimer's Disease Neuroimaging Initiative.

Radiology. 2025 Mar;314(3):e241482. doi: 10.1148/radiol.241482.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias